Wholesale market is growing again for the first time

30.04.2010 12:08

Despite – that’s what they say Andreae-Noris Zahn AG – “difficult overall economic conditions”, the German pharmaceutical market continued to grow from September 2009 to February 2010. The market growth (with an increase in sales of 3.8 %) is driven primarily by the increase in high-priced, innovative drugs that were transferred from the direct business to wholesale supply. This direct result of the 15th amendment to the Medicines Act (AMG), which came into force on August 1, 2009, and in which the full-service pharmaceutical wholesaler received a public supply contract and a legal right to supply from the industry, triggered an increase in sales in the wholesale market of 5.6 % - meaning that it grew faster than the pharmaceutical market for the first time in a long time. The pharmaceutical wholesaler Andreae-Noris Zahn AG (ANZAG), for example, was able to benefit from this, as it was able to increase its sales in the first half of 2010 compared to 2009 - by 5.8 % to 2.1 billion euros. The result increased by 4 million to 22 million euros.